|Bid||216.63 x 800|
|Ask||216.68 x 800|
|Day's Range||210.33 - 216.71|
|52 Week Range||177.05 - 264.97|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||17.69|
|Earnings Date||Jan 28, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||6.40 (2.96%)|
|Ex-Dividend Date||Nov 13, 2020|
|1y Target Est||260.08|
Amgen (AMGN) beats Q3 estimates for both earnings and sales. It slightly narrows its previously issued sales guidance for 2020 while raising its earnings range.
Amgen (AMGN) is trading lower after third quarter earnings and could drop another 20 points in coming weeks.
Without the purchase of the blockbuster autoimmune disease drug, Amgen's latest results wouldn't have looked nearly as good.